Global Oligonucleotide and Peptide Synthesis Market Research Report 2026(Status and Outlook)
Oligonucleotide and peptide synthesis represents a cornerstone technology in modern biotechnology and pharmaceutical industries, referring to the in vitro construction of nucleic acid fragments and peptide chains through chemical or enzymatic methods. Oligonucleotide synthesis, typically achieved by solid-phase synthesis, enables the production of custom-designed DNA or RNA sequences for applications in gene editing, molecular diagnostics, antisense therapeutics, RNA interference, and vaccine development. Peptide synthesis, often carried out via solid-phase peptide synthesis (SPPS) or liquid-phase methods, allows for the creation of tailored peptides used in drug discovery, protein structure-function studies, vaccine design, and advanced biomaterials. With the rise of precision medicine and nucleic acid-based therapeutics, oligonucleotide and peptide synthesis has evolved from a research tool into a critical driver of clinical translation and large-scale pharmaceutical manufacturing.
The global Oligonucleotide and Peptide Synthesis market size was estimated at USD 1021.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oligonucleotide and Peptide Synthesis market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oligonucleotide and Peptide Synthesis market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oligonucleotide and Peptide Synthesis market.
Global Oligonucleotide and Peptide Synthesis Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Thermo Fisher Scientific
Merck
Azenta Life Sciences
BBI Life Sciences
TriLink BioTechnologies
Aurigene Pharmaceutical Services
Integrated DNA Technologies (IDT)
Cusabio
Macrogen
Synbio Technologies
Eurogentec
WuXi TIDES
Genscript
Abace Biotechnology
Tsingke
Guangzhou RiboBio
Atantares
Wuhan GeneCreate Biological Engineering
Beyotime
General Biol
Veliterbio
Market Segmentation (by Type)
Oligonucleotide Synthesis
Peptide Synthesis
Market Segmentation (by Application)
Biotech Company
Academic Scientific Research Institution
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oligonucleotide and Peptide Synthesis Market
Overview of the regional outlook of the Oligonucleotide and Peptide Synthesis Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oligonucleotide and Peptide Synthesis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oligonucleotide and Peptide Synthesis, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Oligonucleotide and Peptide Synthesis market size was estimated at USD 1021.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oligonucleotide and Peptide Synthesis market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oligonucleotide and Peptide Synthesis market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oligonucleotide and Peptide Synthesis market.
Global Oligonucleotide and Peptide Synthesis Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Thermo Fisher Scientific
Merck
Azenta Life Sciences
BBI Life Sciences
TriLink BioTechnologies
Aurigene Pharmaceutical Services
Integrated DNA Technologies (IDT)
Cusabio
Macrogen
Synbio Technologies
Eurogentec
WuXi TIDES
Genscript
Abace Biotechnology
Tsingke
Guangzhou RiboBio
Atantares
Wuhan GeneCreate Biological Engineering
Beyotime
General Biol
Veliterbio
Market Segmentation (by Type)
Oligonucleotide Synthesis
Peptide Synthesis
Market Segmentation (by Application)
Biotech Company
Academic Scientific Research Institution
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oligonucleotide and Peptide Synthesis Market
Overview of the regional outlook of the Oligonucleotide and Peptide Synthesis Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oligonucleotide and Peptide Synthesis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oligonucleotide and Peptide Synthesis, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oligonucleotide and Peptide Synthesis
1.2 Key Market Segments
1.2.1 Oligonucleotide and Peptide Synthesis Segment by Type
1.2.2 Oligonucleotide and Peptide Synthesis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oligonucleotide and Peptide Synthesis Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oligonucleotide and Peptide Synthesis Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oligonucleotide and Peptide Synthesis Product Life Cycle
3.3 Global Oligonucleotide and Peptide Synthesis Sales by Manufacturers (2020-2025)
3.4 Global Oligonucleotide and Peptide Synthesis Revenue Market Share by Manufacturers (2020-2025)
3.5 Oligonucleotide and Peptide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oligonucleotide and Peptide Synthesis Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oligonucleotide and Peptide Synthesis Market Competitive Situation and Trends
3.8.1 Oligonucleotide and Peptide Synthesis Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oligonucleotide and Peptide Synthesis Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS INDUSTRY CHAIN ANALYSIS
4.1 Oligonucleotide and Peptide Synthesis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oligonucleotide and Peptide Synthesis Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oligonucleotide and Peptide Synthesis Market
5.7 ESG Ratings of Leading Companies
6 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oligonucleotide and Peptide Synthesis Sales Market Share by Type (2020-2025)
6.3 Global Oligonucleotide and Peptide Synthesis Market Size by Type (2020-2025)
6.4 Global Oligonucleotide and Peptide Synthesis Price by Type (2020-2025)
7 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oligonucleotide and Peptide Synthesis Market Sales by Application (2020-2025)
7.3 Global Oligonucleotide and Peptide Synthesis Market Size (M USD) by Application (2020-2025)
7.4 Global Oligonucleotide and Peptide Synthesis Sales Growth Rate by Application (2020-2025)
8 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET SALES BY REGION
8.1 Global Oligonucleotide and Peptide Synthesis Sales by Region
8.1.1 Global Oligonucleotide and Peptide Synthesis Sales by Region
8.1.2 Global Oligonucleotide and Peptide Synthesis Sales Market Share by Region
8.2 Global Oligonucleotide and Peptide Synthesis Market Size by Region
8.2.1 Global Oligonucleotide and Peptide Synthesis Market Size by Region
8.2.2 Global Oligonucleotide and Peptide Synthesis Market Size by Region
8.3 North America
8.3.1 North America Oligonucleotide and Peptide Synthesis Sales by Country
8.3.2 North America Oligonucleotide and Peptide Synthesis Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oligonucleotide and Peptide Synthesis Sales by Country
8.4.2 Europe Oligonucleotide and Peptide Synthesis Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oligonucleotide and Peptide Synthesis Sales by Region
8.5.2 Asia Pacific Oligonucleotide and Peptide Synthesis Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oligonucleotide and Peptide Synthesis Sales by Country
8.6.2 South America Oligonucleotide and Peptide Synthesis Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oligonucleotide and Peptide Synthesis Sales by Region
8.7.2 Middle East and Africa Oligonucleotide and Peptide Synthesis Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET PRODUCTION BY REGION
9.1 Global Production of Oligonucleotide and Peptide Synthesis by Region(2020-2025)
9.2 Global Oligonucleotide and Peptide Synthesis Revenue Market Share by Region (2020-2025)
9.3 Global Oligonucleotide and Peptide Synthesis Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oligonucleotide and Peptide Synthesis Production
9.4.1 North America Oligonucleotide and Peptide Synthesis Production Growth Rate (2020-2025)
9.4.2 North America Oligonucleotide and Peptide Synthesis Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oligonucleotide and Peptide Synthesis Production
9.5.1 Europe Oligonucleotide and Peptide Synthesis Production Growth Rate (2020-2025)
9.5.2 Europe Oligonucleotide and Peptide Synthesis Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oligonucleotide and Peptide Synthesis Production (2020-2025)
9.6.1 Japan Oligonucleotide and Peptide Synthesis Production Growth Rate (2020-2025)
9.6.2 Japan Oligonucleotide and Peptide Synthesis Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oligonucleotide and Peptide Synthesis Production (2020-2025)
9.7.1 China Oligonucleotide and Peptide Synthesis Production Growth Rate (2020-2025)
9.7.2 China Oligonucleotide and Peptide Synthesis Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Thermo Fisher Scientific
10.1.1 Thermo Fisher Scientific Basic Information
10.1.2 Thermo Fisher Scientific Oligonucleotide and Peptide Synthesis Product Overview
10.1.3 Thermo Fisher Scientific Oligonucleotide and Peptide Synthesis Product Market Performance
10.1.4 Thermo Fisher Scientific Business Overview
10.1.5 Thermo Fisher Scientific SWOT Analysis
10.1.6 Thermo Fisher Scientific Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Oligonucleotide and Peptide Synthesis Product Overview
10.2.3 Merck Oligonucleotide and Peptide Synthesis Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Azenta Life Sciences
10.3.1 Azenta Life Sciences Basic Information
10.3.2 Azenta Life Sciences Oligonucleotide and Peptide Synthesis Product Overview
10.3.3 Azenta Life Sciences Oligonucleotide and Peptide Synthesis Product Market Performance
10.3.4 Azenta Life Sciences Business Overview
10.3.5 Azenta Life Sciences SWOT Analysis
10.3.6 Azenta Life Sciences Recent Developments
10.4 BBI Life Sciences
10.4.1 BBI Life Sciences Basic Information
10.4.2 BBI Life Sciences Oligonucleotide and Peptide Synthesis Product Overview
10.4.3 BBI Life Sciences Oligonucleotide and Peptide Synthesis Product Market Performance
10.4.4 BBI Life Sciences Business Overview
10.4.5 BBI Life Sciences Recent Developments
10.5 TriLink BioTechnologies
10.5.1 TriLink BioTechnologies Basic Information
10.5.2 TriLink BioTechnologies Oligonucleotide and Peptide Synthesis Product Overview
10.5.3 TriLink BioTechnologies Oligonucleotide and Peptide Synthesis Product Market Performance
10.5.4 TriLink BioTechnologies Business Overview
10.5.5 TriLink BioTechnologies Recent Developments
10.6 Aurigene Pharmaceutical Services
10.6.1 Aurigene Pharmaceutical Services Basic Information
10.6.2 Aurigene Pharmaceutical Services Oligonucleotide and Peptide Synthesis Product Overview
10.6.3 Aurigene Pharmaceutical Services Oligonucleotide and Peptide Synthesis Product Market Performance
10.6.4 Aurigene Pharmaceutical Services Business Overview
10.6.5 Aurigene Pharmaceutical Services Recent Developments
10.7 Integrated DNA Technologies (IDT)
10.7.1 Integrated DNA Technologies (IDT) Basic Information
10.7.2 Integrated DNA Technologies (IDT) Oligonucleotide and Peptide Synthesis Product Overview
10.7.3 Integrated DNA Technologies (IDT) Oligonucleotide and Peptide Synthesis Product Market Performance
10.7.4 Integrated DNA Technologies (IDT) Business Overview
10.7.5 Integrated DNA Technologies (IDT) Recent Developments
10.8 Cusabio
10.8.1 Cusabio Basic Information
10.8.2 Cusabio Oligonucleotide and Peptide Synthesis Product Overview
10.8.3 Cusabio Oligonucleotide and Peptide Synthesis Product Market Performance
10.8.4 Cusabio Business Overview
10.8.5 Cusabio Recent Developments
10.9 Macrogen
10.9.1 Macrogen Basic Information
10.9.2 Macrogen Oligonucleotide and Peptide Synthesis Product Overview
10.9.3 Macrogen Oligonucleotide and Peptide Synthesis Product Market Performance
10.9.4 Macrogen Business Overview
10.9.5 Macrogen Recent Developments
10.10 Synbio Technologies
10.10.1 Synbio Technologies Basic Information
10.10.2 Synbio Technologies Oligonucleotide and Peptide Synthesis Product Overview
10.10.3 Synbio Technologies Oligonucleotide and Peptide Synthesis Product Market Performance
10.10.4 Synbio Technologies Business Overview
10.10.5 Synbio Technologies Recent Developments
10.11 Eurogentec
10.11.1 Eurogentec Basic Information
10.11.2 Eurogentec Oligonucleotide and Peptide Synthesis Product Overview
10.11.3 Eurogentec Oligonucleotide and Peptide Synthesis Product Market Performance
10.11.4 Eurogentec Business Overview
10.11.5 Eurogentec Recent Developments
10.12 WuXi TIDES
10.12.1 WuXi TIDES Basic Information
10.12.2 WuXi TIDES Oligonucleotide and Peptide Synthesis Product Overview
10.12.3 WuXi TIDES Oligonucleotide and Peptide Synthesis Product Market Performance
10.12.4 WuXi TIDES Business Overview
10.12.5 WuXi TIDES Recent Developments
10.13 Genscript
10.13.1 Genscript Basic Information
10.13.2 Genscript Oligonucleotide and Peptide Synthesis Product Overview
10.13.3 Genscript Oligonucleotide and Peptide Synthesis Product Market Performance
10.13.4 Genscript Business Overview
10.13.5 Genscript Recent Developments
10.14 Abace Biotechnology
10.14.1 Abace Biotechnology Basic Information
10.14.2 Abace Biotechnology Oligonucleotide and Peptide Synthesis Product Overview
10.14.3 Abace Biotechnology Oligonucleotide and Peptide Synthesis Product Market Performance
10.14.4 Abace Biotechnology Business Overview
10.14.5 Abace Biotechnology Recent Developments
10.15 Tsingke
10.15.1 Tsingke Basic Information
10.15.2 Tsingke Oligonucleotide and Peptide Synthesis Product Overview
10.15.3 Tsingke Oligonucleotide and Peptide Synthesis Product Market Performance
10.15.4 Tsingke Business Overview
10.15.5 Tsingke Recent Developments
10.16 Guangzhou RiboBio
10.16.1 Guangzhou RiboBio Basic Information
10.16.2 Guangzhou RiboBio Oligonucleotide and Peptide Synthesis Product Overview
10.16.3 Guangzhou RiboBio Oligonucleotide and Peptide Synthesis Product Market Performance
10.16.4 Guangzhou RiboBio Business Overview
10.16.5 Guangzhou RiboBio Recent Developments
10.17 Atantares
10.17.1 Atantares Basic Information
10.17.2 Atantares Oligonucleotide and Peptide Synthesis Product Overview
10.17.3 Atantares Oligonucleotide and Peptide Synthesis Product Market Performance
10.17.4 Atantares Business Overview
10.17.5 Atantares Recent Developments
10.18 Wuhan GeneCreate Biological Engineering
10.18.1 Wuhan GeneCreate Biological Engineering Basic Information
10.18.2 Wuhan GeneCreate Biological Engineering Oligonucleotide and Peptide Synthesis Product Overview
10.18.3 Wuhan GeneCreate Biological Engineering Oligonucleotide and Peptide Synthesis Product Market Performance
10.18.4 Wuhan GeneCreate Biological Engineering Business Overview
10.18.5 Wuhan GeneCreate Biological Engineering Recent Developments
10.19 Beyotime
10.19.1 Beyotime Basic Information
10.19.2 Beyotime Oligonucleotide and Peptide Synthesis Product Overview
10.19.3 Beyotime Oligonucleotide and Peptide Synthesis Product Market Performance
10.19.4 Beyotime Business Overview
10.19.5 Beyotime Recent Developments
10.20 General Biol
10.20.1 General Biol Basic Information
10.20.2 General Biol Oligonucleotide and Peptide Synthesis Product Overview
10.20.3 General Biol Oligonucleotide and Peptide Synthesis Product Market Performance
10.20.4 General Biol Business Overview
10.20.5 General Biol Recent Developments
10.21 Veliterbio
10.21.1 Veliterbio Basic Information
10.21.2 Veliterbio Oligonucleotide and Peptide Synthesis Product Overview
10.21.3 Veliterbio Oligonucleotide and Peptide Synthesis Product Market Performance
10.21.4 Veliterbio Business Overview
10.21.5 Veliterbio Recent Developments
11 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET FORECAST BY REGION
11.1 Global Oligonucleotide and Peptide Synthesis Market Size Forecast
11.2 Global Oligonucleotide and Peptide Synthesis Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oligonucleotide and Peptide Synthesis Market Size Forecast by Country
11.2.3 Asia Pacific Oligonucleotide and Peptide Synthesis Market Size Forecast by Region
11.2.4 South America Oligonucleotide and Peptide Synthesis Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oligonucleotide and Peptide Synthesis by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oligonucleotide and Peptide Synthesis Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oligonucleotide and Peptide Synthesis by Type (2026-2035)
12.1.2 Global Oligonucleotide and Peptide Synthesis Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oligonucleotide and Peptide Synthesis by Type (2026-2035)
12.2 Global Oligonucleotide and Peptide Synthesis Market Forecast by Application (2026-2035)
12.2.1 Global Oligonucleotide and Peptide Synthesis Sales (K Units) Forecast by Application
12.2.2 Global Oligonucleotide and Peptide Synthesis Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oligonucleotide and Peptide Synthesis
1.2 Key Market Segments
1.2.1 Oligonucleotide and Peptide Synthesis Segment by Type
1.2.2 Oligonucleotide and Peptide Synthesis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oligonucleotide and Peptide Synthesis Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oligonucleotide and Peptide Synthesis Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oligonucleotide and Peptide Synthesis Product Life Cycle
3.3 Global Oligonucleotide and Peptide Synthesis Sales by Manufacturers (2020-2025)
3.4 Global Oligonucleotide and Peptide Synthesis Revenue Market Share by Manufacturers (2020-2025)
3.5 Oligonucleotide and Peptide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oligonucleotide and Peptide Synthesis Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oligonucleotide and Peptide Synthesis Market Competitive Situation and Trends
3.8.1 Oligonucleotide and Peptide Synthesis Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oligonucleotide and Peptide Synthesis Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS INDUSTRY CHAIN ANALYSIS
4.1 Oligonucleotide and Peptide Synthesis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oligonucleotide and Peptide Synthesis Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oligonucleotide and Peptide Synthesis Market
5.7 ESG Ratings of Leading Companies
6 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oligonucleotide and Peptide Synthesis Sales Market Share by Type (2020-2025)
6.3 Global Oligonucleotide and Peptide Synthesis Market Size by Type (2020-2025)
6.4 Global Oligonucleotide and Peptide Synthesis Price by Type (2020-2025)
7 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oligonucleotide and Peptide Synthesis Market Sales by Application (2020-2025)
7.3 Global Oligonucleotide and Peptide Synthesis Market Size (M USD) by Application (2020-2025)
7.4 Global Oligonucleotide and Peptide Synthesis Sales Growth Rate by Application (2020-2025)
8 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET SALES BY REGION
8.1 Global Oligonucleotide and Peptide Synthesis Sales by Region
8.1.1 Global Oligonucleotide and Peptide Synthesis Sales by Region
8.1.2 Global Oligonucleotide and Peptide Synthesis Sales Market Share by Region
8.2 Global Oligonucleotide and Peptide Synthesis Market Size by Region
8.2.1 Global Oligonucleotide and Peptide Synthesis Market Size by Region
8.2.2 Global Oligonucleotide and Peptide Synthesis Market Size by Region
8.3 North America
8.3.1 North America Oligonucleotide and Peptide Synthesis Sales by Country
8.3.2 North America Oligonucleotide and Peptide Synthesis Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oligonucleotide and Peptide Synthesis Sales by Country
8.4.2 Europe Oligonucleotide and Peptide Synthesis Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oligonucleotide and Peptide Synthesis Sales by Region
8.5.2 Asia Pacific Oligonucleotide and Peptide Synthesis Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oligonucleotide and Peptide Synthesis Sales by Country
8.6.2 South America Oligonucleotide and Peptide Synthesis Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oligonucleotide and Peptide Synthesis Sales by Region
8.7.2 Middle East and Africa Oligonucleotide and Peptide Synthesis Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET PRODUCTION BY REGION
9.1 Global Production of Oligonucleotide and Peptide Synthesis by Region(2020-2025)
9.2 Global Oligonucleotide and Peptide Synthesis Revenue Market Share by Region (2020-2025)
9.3 Global Oligonucleotide and Peptide Synthesis Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oligonucleotide and Peptide Synthesis Production
9.4.1 North America Oligonucleotide and Peptide Synthesis Production Growth Rate (2020-2025)
9.4.2 North America Oligonucleotide and Peptide Synthesis Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oligonucleotide and Peptide Synthesis Production
9.5.1 Europe Oligonucleotide and Peptide Synthesis Production Growth Rate (2020-2025)
9.5.2 Europe Oligonucleotide and Peptide Synthesis Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oligonucleotide and Peptide Synthesis Production (2020-2025)
9.6.1 Japan Oligonucleotide and Peptide Synthesis Production Growth Rate (2020-2025)
9.6.2 Japan Oligonucleotide and Peptide Synthesis Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oligonucleotide and Peptide Synthesis Production (2020-2025)
9.7.1 China Oligonucleotide and Peptide Synthesis Production Growth Rate (2020-2025)
9.7.2 China Oligonucleotide and Peptide Synthesis Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Thermo Fisher Scientific
10.1.1 Thermo Fisher Scientific Basic Information
10.1.2 Thermo Fisher Scientific Oligonucleotide and Peptide Synthesis Product Overview
10.1.3 Thermo Fisher Scientific Oligonucleotide and Peptide Synthesis Product Market Performance
10.1.4 Thermo Fisher Scientific Business Overview
10.1.5 Thermo Fisher Scientific SWOT Analysis
10.1.6 Thermo Fisher Scientific Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Oligonucleotide and Peptide Synthesis Product Overview
10.2.3 Merck Oligonucleotide and Peptide Synthesis Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Azenta Life Sciences
10.3.1 Azenta Life Sciences Basic Information
10.3.2 Azenta Life Sciences Oligonucleotide and Peptide Synthesis Product Overview
10.3.3 Azenta Life Sciences Oligonucleotide and Peptide Synthesis Product Market Performance
10.3.4 Azenta Life Sciences Business Overview
10.3.5 Azenta Life Sciences SWOT Analysis
10.3.6 Azenta Life Sciences Recent Developments
10.4 BBI Life Sciences
10.4.1 BBI Life Sciences Basic Information
10.4.2 BBI Life Sciences Oligonucleotide and Peptide Synthesis Product Overview
10.4.3 BBI Life Sciences Oligonucleotide and Peptide Synthesis Product Market Performance
10.4.4 BBI Life Sciences Business Overview
10.4.5 BBI Life Sciences Recent Developments
10.5 TriLink BioTechnologies
10.5.1 TriLink BioTechnologies Basic Information
10.5.2 TriLink BioTechnologies Oligonucleotide and Peptide Synthesis Product Overview
10.5.3 TriLink BioTechnologies Oligonucleotide and Peptide Synthesis Product Market Performance
10.5.4 TriLink BioTechnologies Business Overview
10.5.5 TriLink BioTechnologies Recent Developments
10.6 Aurigene Pharmaceutical Services
10.6.1 Aurigene Pharmaceutical Services Basic Information
10.6.2 Aurigene Pharmaceutical Services Oligonucleotide and Peptide Synthesis Product Overview
10.6.3 Aurigene Pharmaceutical Services Oligonucleotide and Peptide Synthesis Product Market Performance
10.6.4 Aurigene Pharmaceutical Services Business Overview
10.6.5 Aurigene Pharmaceutical Services Recent Developments
10.7 Integrated DNA Technologies (IDT)
10.7.1 Integrated DNA Technologies (IDT) Basic Information
10.7.2 Integrated DNA Technologies (IDT) Oligonucleotide and Peptide Synthesis Product Overview
10.7.3 Integrated DNA Technologies (IDT) Oligonucleotide and Peptide Synthesis Product Market Performance
10.7.4 Integrated DNA Technologies (IDT) Business Overview
10.7.5 Integrated DNA Technologies (IDT) Recent Developments
10.8 Cusabio
10.8.1 Cusabio Basic Information
10.8.2 Cusabio Oligonucleotide and Peptide Synthesis Product Overview
10.8.3 Cusabio Oligonucleotide and Peptide Synthesis Product Market Performance
10.8.4 Cusabio Business Overview
10.8.5 Cusabio Recent Developments
10.9 Macrogen
10.9.1 Macrogen Basic Information
10.9.2 Macrogen Oligonucleotide and Peptide Synthesis Product Overview
10.9.3 Macrogen Oligonucleotide and Peptide Synthesis Product Market Performance
10.9.4 Macrogen Business Overview
10.9.5 Macrogen Recent Developments
10.10 Synbio Technologies
10.10.1 Synbio Technologies Basic Information
10.10.2 Synbio Technologies Oligonucleotide and Peptide Synthesis Product Overview
10.10.3 Synbio Technologies Oligonucleotide and Peptide Synthesis Product Market Performance
10.10.4 Synbio Technologies Business Overview
10.10.5 Synbio Technologies Recent Developments
10.11 Eurogentec
10.11.1 Eurogentec Basic Information
10.11.2 Eurogentec Oligonucleotide and Peptide Synthesis Product Overview
10.11.3 Eurogentec Oligonucleotide and Peptide Synthesis Product Market Performance
10.11.4 Eurogentec Business Overview
10.11.5 Eurogentec Recent Developments
10.12 WuXi TIDES
10.12.1 WuXi TIDES Basic Information
10.12.2 WuXi TIDES Oligonucleotide and Peptide Synthesis Product Overview
10.12.3 WuXi TIDES Oligonucleotide and Peptide Synthesis Product Market Performance
10.12.4 WuXi TIDES Business Overview
10.12.5 WuXi TIDES Recent Developments
10.13 Genscript
10.13.1 Genscript Basic Information
10.13.2 Genscript Oligonucleotide and Peptide Synthesis Product Overview
10.13.3 Genscript Oligonucleotide and Peptide Synthesis Product Market Performance
10.13.4 Genscript Business Overview
10.13.5 Genscript Recent Developments
10.14 Abace Biotechnology
10.14.1 Abace Biotechnology Basic Information
10.14.2 Abace Biotechnology Oligonucleotide and Peptide Synthesis Product Overview
10.14.3 Abace Biotechnology Oligonucleotide and Peptide Synthesis Product Market Performance
10.14.4 Abace Biotechnology Business Overview
10.14.5 Abace Biotechnology Recent Developments
10.15 Tsingke
10.15.1 Tsingke Basic Information
10.15.2 Tsingke Oligonucleotide and Peptide Synthesis Product Overview
10.15.3 Tsingke Oligonucleotide and Peptide Synthesis Product Market Performance
10.15.4 Tsingke Business Overview
10.15.5 Tsingke Recent Developments
10.16 Guangzhou RiboBio
10.16.1 Guangzhou RiboBio Basic Information
10.16.2 Guangzhou RiboBio Oligonucleotide and Peptide Synthesis Product Overview
10.16.3 Guangzhou RiboBio Oligonucleotide and Peptide Synthesis Product Market Performance
10.16.4 Guangzhou RiboBio Business Overview
10.16.5 Guangzhou RiboBio Recent Developments
10.17 Atantares
10.17.1 Atantares Basic Information
10.17.2 Atantares Oligonucleotide and Peptide Synthesis Product Overview
10.17.3 Atantares Oligonucleotide and Peptide Synthesis Product Market Performance
10.17.4 Atantares Business Overview
10.17.5 Atantares Recent Developments
10.18 Wuhan GeneCreate Biological Engineering
10.18.1 Wuhan GeneCreate Biological Engineering Basic Information
10.18.2 Wuhan GeneCreate Biological Engineering Oligonucleotide and Peptide Synthesis Product Overview
10.18.3 Wuhan GeneCreate Biological Engineering Oligonucleotide and Peptide Synthesis Product Market Performance
10.18.4 Wuhan GeneCreate Biological Engineering Business Overview
10.18.5 Wuhan GeneCreate Biological Engineering Recent Developments
10.19 Beyotime
10.19.1 Beyotime Basic Information
10.19.2 Beyotime Oligonucleotide and Peptide Synthesis Product Overview
10.19.3 Beyotime Oligonucleotide and Peptide Synthesis Product Market Performance
10.19.4 Beyotime Business Overview
10.19.5 Beyotime Recent Developments
10.20 General Biol
10.20.1 General Biol Basic Information
10.20.2 General Biol Oligonucleotide and Peptide Synthesis Product Overview
10.20.3 General Biol Oligonucleotide and Peptide Synthesis Product Market Performance
10.20.4 General Biol Business Overview
10.20.5 General Biol Recent Developments
10.21 Veliterbio
10.21.1 Veliterbio Basic Information
10.21.2 Veliterbio Oligonucleotide and Peptide Synthesis Product Overview
10.21.3 Veliterbio Oligonucleotide and Peptide Synthesis Product Market Performance
10.21.4 Veliterbio Business Overview
10.21.5 Veliterbio Recent Developments
11 OLIGONUCLEOTIDE AND PEPTIDE SYNTHESIS MARKET FORECAST BY REGION
11.1 Global Oligonucleotide and Peptide Synthesis Market Size Forecast
11.2 Global Oligonucleotide and Peptide Synthesis Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oligonucleotide and Peptide Synthesis Market Size Forecast by Country
11.2.3 Asia Pacific Oligonucleotide and Peptide Synthesis Market Size Forecast by Region
11.2.4 South America Oligonucleotide and Peptide Synthesis Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oligonucleotide and Peptide Synthesis by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oligonucleotide and Peptide Synthesis Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oligonucleotide and Peptide Synthesis by Type (2026-2035)
12.1.2 Global Oligonucleotide and Peptide Synthesis Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oligonucleotide and Peptide Synthesis by Type (2026-2035)
12.2 Global Oligonucleotide and Peptide Synthesis Market Forecast by Application (2026-2035)
12.2.1 Global Oligonucleotide and Peptide Synthesis Sales (K Units) Forecast by Application
12.2.2 Global Oligonucleotide and Peptide Synthesis Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oligonucleotide and Peptide Synthesis Market Size by Type (M USD)
Table 4. Global Oligonucleotide and Peptide Synthesis Market Size by Application
Table 5. Oligonucleotide and Peptide Synthesis Market Size Comparison by Region (M USD)
Table 6. Global Oligonucleotide and Peptide Synthesis Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oligonucleotide and Peptide Synthesis Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oligonucleotide and Peptide Synthesis Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide and Peptide Synthesis as of 2025)
Table 11. Global Market Oligonucleotide and Peptide Synthesis Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oligonucleotide and Peptide Synthesis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oligonucleotide and Peptide Synthesis Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oligonucleotide and Peptide Synthesis Sales by Type (K Units)
Table 27. Global Oligonucleotide and Peptide Synthesis Market Size by Type (M USD)
Table 28. Global Oligonucleotide and Peptide Synthesis Sales (K Units) by Type (2020-2025)
Table 29. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Type (2020-2025)
Table 30. Global Oligonucleotide and Peptide Synthesis Market Size (M USD) by Type (2020-2025)
Table 31. Global Oligonucleotide and Peptide Synthesis Market Share by Type (2020-2025)
Table 32. Global Oligonucleotide and Peptide Synthesis Price (USD/Unit) by Type (2020-2025)
Table 33. Global Oligonucleotide and Peptide Synthesis Sales (K Units) by Application
Table 34. Global Oligonucleotide and Peptide Synthesis Market Size by Application
Table 35. Global Oligonucleotide and Peptide Synthesis Sales by Application (2020-2025) & (K Units)
Table 36. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Application (2020-2025)
Table 37. Global Oligonucleotide and Peptide Synthesis Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oligonucleotide and Peptide Synthesis Market Share by Application (2020-2025)
Table 39. Global Oligonucleotide and Peptide Synthesis Sales Growth Rate by Application (2020-2025)
Table 40. Global Oligonucleotide and Peptide Synthesis Sales by Region (2020-2025) & (K Units)
Table 41. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Region (2020-2025)
Table 42. Global Oligonucleotide and Peptide Synthesis Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oligonucleotide and Peptide Synthesis Market Size by Region (2020-2025)
Table 44. North America Oligonucleotide and Peptide Synthesis Sales by Country (2020-2025) & (K Units)
Table 45. North America Oligonucleotide and Peptide Synthesis Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oligonucleotide and Peptide Synthesis Sales by Country (2020-2025) & (K Units)
Table 47. Europe Oligonucleotide and Peptide Synthesis Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oligonucleotide and Peptide Synthesis Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Oligonucleotide and Peptide Synthesis Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oligonucleotide and Peptide Synthesis Sales by Country (2020-2025) & (K Units)
Table 51. South America Oligonucleotide and Peptide Synthesis Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oligonucleotide and Peptide Synthesis Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Oligonucleotide and Peptide Synthesis Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oligonucleotide and Peptide Synthesis Production (K Units) by Region(2020-2025)
Table 55. Global Oligonucleotide and Peptide Synthesis Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oligonucleotide and Peptide Synthesis Revenue Market Share by Region (2020-2025)
Table 57. Global Oligonucleotide and Peptide Synthesis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Oligonucleotide and Peptide Synthesis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Oligonucleotide and Peptide Synthesis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Oligonucleotide and Peptide Synthesis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Oligonucleotide and Peptide Synthesis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Thermo Fisher Scientific Basic Information
Table 63. Thermo Fisher Scientific Oligonucleotide and Peptide Synthesis Product Overview
Table 64. Thermo Fisher Scientific Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Thermo Fisher Scientific Business Overview
Table 66. Thermo Fisher Scientific SWOT Analysis
Table 67. Thermo Fisher Scientific Recent Developments
Table 68. Merck Basic Information
Table 69. Merck Oligonucleotide and Peptide Synthesis Product Overview
Table 70. Merck Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Merck Business Overview
Table 72. Merck SWOT Analysis
Table 73. Merck Recent Developments
Table 74. Azenta Life Sciences Basic Information
Table 75. Azenta Life Sciences Oligonucleotide and Peptide Synthesis Product Overview
Table 76. Azenta Life Sciences Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Azenta Life Sciences Business Overview
Table 78. Azenta Life Sciences SWOT Analysis
Table 79. Azenta Life Sciences Recent Developments
Table 80. BBI Life Sciences Basic Information
Table 81. BBI Life Sciences Oligonucleotide and Peptide Synthesis Product Overview
Table 82. BBI Life Sciences Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. BBI Life Sciences Business Overview
Table 84. BBI Life Sciences Recent Developments
Table 85. TriLink BioTechnologies Basic Information
Table 86. TriLink BioTechnologies Oligonucleotide and Peptide Synthesis Product Overview
Table 87. TriLink BioTechnologies Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. TriLink BioTechnologies Business Overview
Table 89. TriLink BioTechnologies Recent Developments
Table 90. Aurigene Pharmaceutical Services Basic Information
Table 91. Aurigene Pharmaceutical Services Oligonucleotide and Peptide Synthesis Product Overview
Table 92. Aurigene Pharmaceutical Services Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Aurigene Pharmaceutical Services Business Overview
Table 94. Aurigene Pharmaceutical Services Recent Developments
Table 95. Integrated DNA Technologies (IDT) Basic Information
Table 96. Integrated DNA Technologies (IDT) Oligonucleotide and Peptide Synthesis Product Overview
Table 97. Integrated DNA Technologies (IDT) Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Integrated DNA Technologies (IDT) Business Overview
Table 99. Integrated DNA Technologies (IDT) Recent Developments
Table 100. Cusabio Basic Information
Table 101. Cusabio Oligonucleotide and Peptide Synthesis Product Overview
Table 102. Cusabio Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cusabio Business Overview
Table 104. Cusabio Recent Developments
Table 105. Macrogen Basic Information
Table 106. Macrogen Oligonucleotide and Peptide Synthesis Product Overview
Table 107. Macrogen Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Macrogen Business Overview
Table 109. Macrogen Recent Developments
Table 110. Synbio Technologies Basic Information
Table 111. Synbio Technologies Oligonucleotide and Peptide Synthesis Product Overview
Table 112. Synbio Technologies Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Synbio Technologies Business Overview
Table 114. Synbio Technologies Recent Developments
Table 115. Eurogentec Basic Information
Table 116. Eurogentec Oligonucleotide and Peptide Synthesis Product Overview
Table 117. Eurogentec Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Eurogentec Business Overview
Table 119. Eurogentec Recent Developments
Table 120. WuXi TIDES Basic Information
Table 121. WuXi TIDES Oligonucleotide and Peptide Synthesis Product Overview
Table 122. WuXi TIDES Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. WuXi TIDES Business Overview
Table 124. WuXi TIDES Recent Developments
Table 125. Genscript Basic Information
Table 126. Genscript Oligonucleotide and Peptide Synthesis Product Overview
Table 127. Genscript Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Genscript Business Overview
Table 129. Genscript Recent Developments
Table 130. Abace Biotechnology Basic Information
Table 131. Abace Biotechnology Oligonucleotide and Peptide Synthesis Product Overview
Table 132. Abace Biotechnology Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Abace Biotechnology Business Overview
Table 134. Abace Biotechnology Recent Developments
Table 135. Tsingke Basic Information
Table 136. Tsingke Oligonucleotide and Peptide Synthesis Product Overview
Table 137. Tsingke Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Tsingke Business Overview
Table 139. Tsingke Recent Developments
Table 140. Guangzhou RiboBio Basic Information
Table 141. Guangzhou RiboBio Oligonucleotide and Peptide Synthesis Product Overview
Table 142. Guangzhou RiboBio Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Guangzhou RiboBio Business Overview
Table 144. Guangzhou RiboBio Recent Developments
Table 145. Atantares Basic Information
Table 146. Atantares Oligonucleotide and Peptide Synthesis Product Overview
Table 147. Atantares Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Atantares Business Overview
Table 149. Atantares Recent Developments
Table 150. Wuhan GeneCreate Biological Engineering Basic Information
Table 151. Wuhan GeneCreate Biological Engineering Oligonucleotide and Peptide Synthesis Product Overview
Table 152. Wuhan GeneCreate Biological Engineering Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Wuhan GeneCreate Biological Engineering Business Overview
Table 154. Wuhan GeneCreate Biological Engineering Recent Developments
Table 155. Beyotime Basic Information
Table 156. Beyotime Oligonucleotide and Peptide Synthesis Product Overview
Table 157. Beyotime Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Beyotime Business Overview
Table 159. Beyotime Recent Developments
Table 160. General Biol Basic Information
Table 161. General Biol Oligonucleotide and Peptide Synthesis Product Overview
Table 162. General Biol Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. General Biol Business Overview
Table 164. General Biol Recent Developments
Table 165. Veliterbio Basic Information
Table 166. Veliterbio Oligonucleotide and Peptide Synthesis Product Overview
Table 167. Veliterbio Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Veliterbio Business Overview
Table 169. Veliterbio Recent Developments
Table 170. Global Oligonucleotide and Peptide Synthesis Sales Forecast by Region (2026-2035) & (K Units)
Table 171. Global Oligonucleotide and Peptide Synthesis Market Size Forecast by Region (2026-2035) & (M USD)
Table 172. North America Oligonucleotide and Peptide Synthesis Sales Forecast by Country (2026-2035) & (K Units)
Table 173. North America Oligonucleotide and Peptide Synthesis Market Size Forecast by Country (2026-2035) & (M USD)
Table 174. Europe Oligonucleotide and Peptide Synthesis Sales Forecast by Country (2026-2035) & (K Units)
Table 175. Europe Oligonucleotide and Peptide Synthesis Market Size Forecast by Country (2026-2035) & (M USD)
Table 176. Asia Pacific Oligonucleotide and Peptide Synthesis Sales Forecast by Region (2026-2035) & (K Units)
Table 177. Asia Pacific Oligonucleotide and Peptide Synthesis Market Size Forecast by Region (2026-2035) & (M USD)
Table 178. South America Oligonucleotide and Peptide Synthesis Sales Forecast by Country (2026-2035) & (K Units)
Table 179. South America Oligonucleotide and Peptide Synthesis Market Size Forecast by Country (2026-2035) & (M USD)
Table 180. Middle East and Africa Oligonucleotide and Peptide Synthesis Sales Forecast by Country (2026-2035) & (Units)
Table 181. Middle East and Africa Oligonucleotide and Peptide Synthesis Market Size Forecast by Country (2026-2035) & (M USD)
Table 182. Global Oligonucleotide and Peptide Synthesis Sales Forecast by Type (2026-2035) & (K Units)
Table 183. Global Oligonucleotide and Peptide Synthesis Market Size Forecast by Type (2026-2035) & (M USD)
Table 184. Global Oligonucleotide and Peptide Synthesis Price Forecast by Type (2026-2035) & (USD/Unit)
Table 185. Global Oligonucleotide and Peptide Synthesis Sales (K Units) Forecast by Application (2026-2035)
Table 186. Global Oligonucleotide and Peptide Synthesis Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oligonucleotide and Peptide Synthesis Market Size by Type (M USD)
Table 4. Global Oligonucleotide and Peptide Synthesis Market Size by Application
Table 5. Oligonucleotide and Peptide Synthesis Market Size Comparison by Region (M USD)
Table 6. Global Oligonucleotide and Peptide Synthesis Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oligonucleotide and Peptide Synthesis Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oligonucleotide and Peptide Synthesis Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide and Peptide Synthesis as of 2025)
Table 11. Global Market Oligonucleotide and Peptide Synthesis Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oligonucleotide and Peptide Synthesis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oligonucleotide and Peptide Synthesis Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oligonucleotide and Peptide Synthesis Sales by Type (K Units)
Table 27. Global Oligonucleotide and Peptide Synthesis Market Size by Type (M USD)
Table 28. Global Oligonucleotide and Peptide Synthesis Sales (K Units) by Type (2020-2025)
Table 29. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Type (2020-2025)
Table 30. Global Oligonucleotide and Peptide Synthesis Market Size (M USD) by Type (2020-2025)
Table 31. Global Oligonucleotide and Peptide Synthesis Market Share by Type (2020-2025)
Table 32. Global Oligonucleotide and Peptide Synthesis Price (USD/Unit) by Type (2020-2025)
Table 33. Global Oligonucleotide and Peptide Synthesis Sales (K Units) by Application
Table 34. Global Oligonucleotide and Peptide Synthesis Market Size by Application
Table 35. Global Oligonucleotide and Peptide Synthesis Sales by Application (2020-2025) & (K Units)
Table 36. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Application (2020-2025)
Table 37. Global Oligonucleotide and Peptide Synthesis Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oligonucleotide and Peptide Synthesis Market Share by Application (2020-2025)
Table 39. Global Oligonucleotide and Peptide Synthesis Sales Growth Rate by Application (2020-2025)
Table 40. Global Oligonucleotide and Peptide Synthesis Sales by Region (2020-2025) & (K Units)
Table 41. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Region (2020-2025)
Table 42. Global Oligonucleotide and Peptide Synthesis Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oligonucleotide and Peptide Synthesis Market Size by Region (2020-2025)
Table 44. North America Oligonucleotide and Peptide Synthesis Sales by Country (2020-2025) & (K Units)
Table 45. North America Oligonucleotide and Peptide Synthesis Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oligonucleotide and Peptide Synthesis Sales by Country (2020-2025) & (K Units)
Table 47. Europe Oligonucleotide and Peptide Synthesis Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oligonucleotide and Peptide Synthesis Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Oligonucleotide and Peptide Synthesis Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oligonucleotide and Peptide Synthesis Sales by Country (2020-2025) & (K Units)
Table 51. South America Oligonucleotide and Peptide Synthesis Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oligonucleotide and Peptide Synthesis Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Oligonucleotide and Peptide Synthesis Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oligonucleotide and Peptide Synthesis Production (K Units) by Region(2020-2025)
Table 55. Global Oligonucleotide and Peptide Synthesis Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oligonucleotide and Peptide Synthesis Revenue Market Share by Region (2020-2025)
Table 57. Global Oligonucleotide and Peptide Synthesis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Oligonucleotide and Peptide Synthesis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Oligonucleotide and Peptide Synthesis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Oligonucleotide and Peptide Synthesis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Oligonucleotide and Peptide Synthesis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Thermo Fisher Scientific Basic Information
Table 63. Thermo Fisher Scientific Oligonucleotide and Peptide Synthesis Product Overview
Table 64. Thermo Fisher Scientific Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Thermo Fisher Scientific Business Overview
Table 66. Thermo Fisher Scientific SWOT Analysis
Table 67. Thermo Fisher Scientific Recent Developments
Table 68. Merck Basic Information
Table 69. Merck Oligonucleotide and Peptide Synthesis Product Overview
Table 70. Merck Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Merck Business Overview
Table 72. Merck SWOT Analysis
Table 73. Merck Recent Developments
Table 74. Azenta Life Sciences Basic Information
Table 75. Azenta Life Sciences Oligonucleotide and Peptide Synthesis Product Overview
Table 76. Azenta Life Sciences Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Azenta Life Sciences Business Overview
Table 78. Azenta Life Sciences SWOT Analysis
Table 79. Azenta Life Sciences Recent Developments
Table 80. BBI Life Sciences Basic Information
Table 81. BBI Life Sciences Oligonucleotide and Peptide Synthesis Product Overview
Table 82. BBI Life Sciences Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. BBI Life Sciences Business Overview
Table 84. BBI Life Sciences Recent Developments
Table 85. TriLink BioTechnologies Basic Information
Table 86. TriLink BioTechnologies Oligonucleotide and Peptide Synthesis Product Overview
Table 87. TriLink BioTechnologies Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. TriLink BioTechnologies Business Overview
Table 89. TriLink BioTechnologies Recent Developments
Table 90. Aurigene Pharmaceutical Services Basic Information
Table 91. Aurigene Pharmaceutical Services Oligonucleotide and Peptide Synthesis Product Overview
Table 92. Aurigene Pharmaceutical Services Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Aurigene Pharmaceutical Services Business Overview
Table 94. Aurigene Pharmaceutical Services Recent Developments
Table 95. Integrated DNA Technologies (IDT) Basic Information
Table 96. Integrated DNA Technologies (IDT) Oligonucleotide and Peptide Synthesis Product Overview
Table 97. Integrated DNA Technologies (IDT) Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Integrated DNA Technologies (IDT) Business Overview
Table 99. Integrated DNA Technologies (IDT) Recent Developments
Table 100. Cusabio Basic Information
Table 101. Cusabio Oligonucleotide and Peptide Synthesis Product Overview
Table 102. Cusabio Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cusabio Business Overview
Table 104. Cusabio Recent Developments
Table 105. Macrogen Basic Information
Table 106. Macrogen Oligonucleotide and Peptide Synthesis Product Overview
Table 107. Macrogen Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Macrogen Business Overview
Table 109. Macrogen Recent Developments
Table 110. Synbio Technologies Basic Information
Table 111. Synbio Technologies Oligonucleotide and Peptide Synthesis Product Overview
Table 112. Synbio Technologies Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Synbio Technologies Business Overview
Table 114. Synbio Technologies Recent Developments
Table 115. Eurogentec Basic Information
Table 116. Eurogentec Oligonucleotide and Peptide Synthesis Product Overview
Table 117. Eurogentec Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Eurogentec Business Overview
Table 119. Eurogentec Recent Developments
Table 120. WuXi TIDES Basic Information
Table 121. WuXi TIDES Oligonucleotide and Peptide Synthesis Product Overview
Table 122. WuXi TIDES Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. WuXi TIDES Business Overview
Table 124. WuXi TIDES Recent Developments
Table 125. Genscript Basic Information
Table 126. Genscript Oligonucleotide and Peptide Synthesis Product Overview
Table 127. Genscript Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Genscript Business Overview
Table 129. Genscript Recent Developments
Table 130. Abace Biotechnology Basic Information
Table 131. Abace Biotechnology Oligonucleotide and Peptide Synthesis Product Overview
Table 132. Abace Biotechnology Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Abace Biotechnology Business Overview
Table 134. Abace Biotechnology Recent Developments
Table 135. Tsingke Basic Information
Table 136. Tsingke Oligonucleotide and Peptide Synthesis Product Overview
Table 137. Tsingke Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Tsingke Business Overview
Table 139. Tsingke Recent Developments
Table 140. Guangzhou RiboBio Basic Information
Table 141. Guangzhou RiboBio Oligonucleotide and Peptide Synthesis Product Overview
Table 142. Guangzhou RiboBio Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Guangzhou RiboBio Business Overview
Table 144. Guangzhou RiboBio Recent Developments
Table 145. Atantares Basic Information
Table 146. Atantares Oligonucleotide and Peptide Synthesis Product Overview
Table 147. Atantares Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Atantares Business Overview
Table 149. Atantares Recent Developments
Table 150. Wuhan GeneCreate Biological Engineering Basic Information
Table 151. Wuhan GeneCreate Biological Engineering Oligonucleotide and Peptide Synthesis Product Overview
Table 152. Wuhan GeneCreate Biological Engineering Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Wuhan GeneCreate Biological Engineering Business Overview
Table 154. Wuhan GeneCreate Biological Engineering Recent Developments
Table 155. Beyotime Basic Information
Table 156. Beyotime Oligonucleotide and Peptide Synthesis Product Overview
Table 157. Beyotime Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Beyotime Business Overview
Table 159. Beyotime Recent Developments
Table 160. General Biol Basic Information
Table 161. General Biol Oligonucleotide and Peptide Synthesis Product Overview
Table 162. General Biol Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. General Biol Business Overview
Table 164. General Biol Recent Developments
Table 165. Veliterbio Basic Information
Table 166. Veliterbio Oligonucleotide and Peptide Synthesis Product Overview
Table 167. Veliterbio Oligonucleotide and Peptide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Veliterbio Business Overview
Table 169. Veliterbio Recent Developments
Table 170. Global Oligonucleotide and Peptide Synthesis Sales Forecast by Region (2026-2035) & (K Units)
Table 171. Global Oligonucleotide and Peptide Synthesis Market Size Forecast by Region (2026-2035) & (M USD)
Table 172. North America Oligonucleotide and Peptide Synthesis Sales Forecast by Country (2026-2035) & (K Units)
Table 173. North America Oligonucleotide and Peptide Synthesis Market Size Forecast by Country (2026-2035) & (M USD)
Table 174. Europe Oligonucleotide and Peptide Synthesis Sales Forecast by Country (2026-2035) & (K Units)
Table 175. Europe Oligonucleotide and Peptide Synthesis Market Size Forecast by Country (2026-2035) & (M USD)
Table 176. Asia Pacific Oligonucleotide and Peptide Synthesis Sales Forecast by Region (2026-2035) & (K Units)
Table 177. Asia Pacific Oligonucleotide and Peptide Synthesis Market Size Forecast by Region (2026-2035) & (M USD)
Table 178. South America Oligonucleotide and Peptide Synthesis Sales Forecast by Country (2026-2035) & (K Units)
Table 179. South America Oligonucleotide and Peptide Synthesis Market Size Forecast by Country (2026-2035) & (M USD)
Table 180. Middle East and Africa Oligonucleotide and Peptide Synthesis Sales Forecast by Country (2026-2035) & (Units)
Table 181. Middle East and Africa Oligonucleotide and Peptide Synthesis Market Size Forecast by Country (2026-2035) & (M USD)
Table 182. Global Oligonucleotide and Peptide Synthesis Sales Forecast by Type (2026-2035) & (K Units)
Table 183. Global Oligonucleotide and Peptide Synthesis Market Size Forecast by Type (2026-2035) & (M USD)
Table 184. Global Oligonucleotide and Peptide Synthesis Price Forecast by Type (2026-2035) & (USD/Unit)
Table 185. Global Oligonucleotide and Peptide Synthesis Sales (K Units) Forecast by Application (2026-2035)
Table 186. Global Oligonucleotide and Peptide Synthesis Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oligonucleotide and Peptide Synthesis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oligonucleotide and Peptide Synthesis Market Size (M USD), 2025-2035
Figure 5. Global Oligonucleotide and Peptide Synthesis Market Size (M USD) (2020-2035)
Figure 6. Global Oligonucleotide and Peptide Synthesis Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oligonucleotide and Peptide Synthesis Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oligonucleotide and Peptide Synthesis Product Life Cycle
Figure 13. Oligonucleotide and Peptide Synthesis Sales Share by Manufacturers in 2025
Figure 14. Global Oligonucleotide and Peptide Synthesis Revenue Share by Manufacturers in 2025
Figure 15. Oligonucleotide and Peptide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oligonucleotide and Peptide Synthesis Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oligonucleotide and Peptide Synthesis Revenue in 2025
Figure 18. Industry Chain Map of Oligonucleotide and Peptide Synthesis
Figure 19. Global Oligonucleotide and Peptide Synthesis Market PEST Analysis
Figure 20. Global Oligonucleotide and Peptide Synthesis Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oligonucleotide and Peptide Synthesis Market Share by Type
Figure 27. Sales Market Share of Oligonucleotide and Peptide Synthesis by Type (2020-2025)
Figure 28. Sales Market Share of Oligonucleotide and Peptide Synthesis by Type in 2025
Figure 29. Market Share of Oligonucleotide and Peptide Synthesis by Type (2020-2025)
Figure 30. Market Share of Oligonucleotide and Peptide Synthesis by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oligonucleotide and Peptide Synthesis Market Share by Application
Figure 33. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Application (2020-2025)
Figure 34. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Application in 2025
Figure 35. Global Oligonucleotide and Peptide Synthesis Market Share by Application (2020-2025)
Figure 36. Global Oligonucleotide and Peptide Synthesis Market Share by Application in 2025
Figure 37. Global Oligonucleotide and Peptide Synthesis Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Region (2020-2025)
Figure 39. Global Oligonucleotide and Peptide Synthesis Market Size by Region (2020-2025)
Figure 40. North America Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Oligonucleotide and Peptide Synthesis Sales Market Share by Country in 2024
Figure 43. North America Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oligonucleotide and Peptide Synthesis Market Size by Country in 2024
Figure 45. U.S. Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oligonucleotide and Peptide Synthesis Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Oligonucleotide and Peptide Synthesis Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oligonucleotide and Peptide Synthesis Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oligonucleotide and Peptide Synthesis Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Oligonucleotide and Peptide Synthesis Sales Market Share by Country in 2024
Figure 53. Europe Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oligonucleotide and Peptide Synthesis Market Size by Country in 2024
Figure 55. Germany Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oligonucleotide and Peptide Synthesis Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Oligonucleotide and Peptide Synthesis Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oligonucleotide and Peptide Synthesis Market Size by Region in 2024
Figure 68. China Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oligonucleotide and Peptide Synthesis Sales and Growth Rate (K Units)
Figure 79. South America Oligonucleotide and Peptide Synthesis Sales Market Share by Country in 2024
Figure 80. South America Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (M USD)
Figure 81. South America Oligonucleotide and Peptide Synthesis Market Size by Country in 2024
Figure 82. Brazil Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oligonucleotide and Peptide Synthesis Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Oligonucleotide and Peptide Synthesis Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oligonucleotide and Peptide Synthesis Market Size by Region in 2024
Figure 92. Saudi Arabia Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oligonucleotide and Peptide Synthesis Production Market Share by Region (2020-2025)
Figure 103. North America Oligonucleotide and Peptide Synthesis Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Oligonucleotide and Peptide Synthesis Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Oligonucleotide and Peptide Synthesis Production (K Units) Growth Rate (2020-2025)
Figure 106. China Oligonucleotide and Peptide Synthesis Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Oligonucleotide and Peptide Synthesis Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Oligonucleotide and Peptide Synthesis Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oligonucleotide and Peptide Synthesis Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oligonucleotide and Peptide Synthesis Market Share Forecast by Type (2026-2035)
Figure 111. Global Oligonucleotide and Peptide Synthesis Sales Forecast by Application (2026-2035)
Figure 112. Global Oligonucleotide and Peptide Synthesis Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Oligonucleotide and Peptide Synthesis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oligonucleotide and Peptide Synthesis Market Size (M USD), 2025-2035
Figure 5. Global Oligonucleotide and Peptide Synthesis Market Size (M USD) (2020-2035)
Figure 6. Global Oligonucleotide and Peptide Synthesis Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oligonucleotide and Peptide Synthesis Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oligonucleotide and Peptide Synthesis Product Life Cycle
Figure 13. Oligonucleotide and Peptide Synthesis Sales Share by Manufacturers in 2025
Figure 14. Global Oligonucleotide and Peptide Synthesis Revenue Share by Manufacturers in 2025
Figure 15. Oligonucleotide and Peptide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oligonucleotide and Peptide Synthesis Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oligonucleotide and Peptide Synthesis Revenue in 2025
Figure 18. Industry Chain Map of Oligonucleotide and Peptide Synthesis
Figure 19. Global Oligonucleotide and Peptide Synthesis Market PEST Analysis
Figure 20. Global Oligonucleotide and Peptide Synthesis Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oligonucleotide and Peptide Synthesis Market Share by Type
Figure 27. Sales Market Share of Oligonucleotide and Peptide Synthesis by Type (2020-2025)
Figure 28. Sales Market Share of Oligonucleotide and Peptide Synthesis by Type in 2025
Figure 29. Market Share of Oligonucleotide and Peptide Synthesis by Type (2020-2025)
Figure 30. Market Share of Oligonucleotide and Peptide Synthesis by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oligonucleotide and Peptide Synthesis Market Share by Application
Figure 33. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Application (2020-2025)
Figure 34. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Application in 2025
Figure 35. Global Oligonucleotide and Peptide Synthesis Market Share by Application (2020-2025)
Figure 36. Global Oligonucleotide and Peptide Synthesis Market Share by Application in 2025
Figure 37. Global Oligonucleotide and Peptide Synthesis Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oligonucleotide and Peptide Synthesis Sales Market Share by Region (2020-2025)
Figure 39. Global Oligonucleotide and Peptide Synthesis Market Size by Region (2020-2025)
Figure 40. North America Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Oligonucleotide and Peptide Synthesis Sales Market Share by Country in 2024
Figure 43. North America Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oligonucleotide and Peptide Synthesis Market Size by Country in 2024
Figure 45. U.S. Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oligonucleotide and Peptide Synthesis Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Oligonucleotide and Peptide Synthesis Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oligonucleotide and Peptide Synthesis Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oligonucleotide and Peptide Synthesis Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Oligonucleotide and Peptide Synthesis Sales Market Share by Country in 2024
Figure 53. Europe Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oligonucleotide and Peptide Synthesis Market Size by Country in 2024
Figure 55. Germany Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oligonucleotide and Peptide Synthesis Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Oligonucleotide and Peptide Synthesis Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oligonucleotide and Peptide Synthesis Market Size by Region in 2024
Figure 68. China Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oligonucleotide and Peptide Synthesis Sales and Growth Rate (K Units)
Figure 79. South America Oligonucleotide and Peptide Synthesis Sales Market Share by Country in 2024
Figure 80. South America Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (M USD)
Figure 81. South America Oligonucleotide and Peptide Synthesis Market Size by Country in 2024
Figure 82. Brazil Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oligonucleotide and Peptide Synthesis Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Oligonucleotide and Peptide Synthesis Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oligonucleotide and Peptide Synthesis Market Size by Region in 2024
Figure 92. Saudi Arabia Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oligonucleotide and Peptide Synthesis Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Oligonucleotide and Peptide Synthesis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oligonucleotide and Peptide Synthesis Production Market Share by Region (2020-2025)
Figure 103. North America Oligonucleotide and Peptide Synthesis Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Oligonucleotide and Peptide Synthesis Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Oligonucleotide and Peptide Synthesis Production (K Units) Growth Rate (2020-2025)
Figure 106. China Oligonucleotide and Peptide Synthesis Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Oligonucleotide and Peptide Synthesis Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Oligonucleotide and Peptide Synthesis Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oligonucleotide and Peptide Synthesis Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oligonucleotide and Peptide Synthesis Market Share Forecast by Type (2026-2035)
Figure 111. Global Oligonucleotide and Peptide Synthesis Sales Forecast by Application (2026-2035)
Figure 112. Global Oligonucleotide and Peptide Synthesis Market Share Forecast by Application (2026-2035)
